Compare Vaxcyte Inc. Common Stock (PCVX) vs Rollins Inc. Common Stock (ROL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Vaxcyte Inc. Common Stock vs Rollins Inc. Common Stock — how do they compare? Vaxcyte Inc. Common Stock trades at $67.37 (market cap $10.51B), while Rollins Inc. Common Stock trades at $32.61 (market cap $15.47B). The key difference: Rollins Inc. Common Stock is the larger of the two by market cap, and Rollins Inc. Common Stock pays a 2.27% dividend while Vaxcyte Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Vaxcyte Inc. Common Stock for 0 Days and Rollins Inc. Common Stock for 0 Days on average.
| PCVX | ROL | |
|---|---|---|
Market Cap | $10.51B | $15.47B |
Volume | 2,644,694 | 6,712,154 |
Sector | Health | Industrials |
52-Week High | $73.82 | $65.60 |
52-Week Low | $40.32 | $29.69 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $9.14B | $16.48B |
Dividend Yield | — | 2.27% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Vaxcyte Inc. Common Stock
Vaxcyte, Inc. is a clinical-stage vaccine company that engineers protein-based vaccines to prevent bacterial diseases such as invasive pneumococcal disease, using its proprietary cell-free protein synthesis platform to develop candidates including the pneumococcal conjugate vaccines VAX-31 and VAX-24.
Read more on PCVX →About Rollins Inc. Common Stock
Rollins Inc. provides pest control services to residential and commercial customers through its family of brands, including Orkin, across dozens of countries.
Read more on ROL →
